| Literature DB >> 16298040 |
J K Hess-Wilson1, K E Knudsen.
Abstract
Prostate cancer is a major health concern and is treated based on its hormone dependence. Agents that alter hormone action can have substantial biological effects on prostate cancer development and progression. As such, there is significant interest in uncovering the potential effects of endocrine disrupting compound (EDC) exposure on prostate cancer. The present review is focused on agents that alter hormone action in the prostate and how they may impact cancer growth or treatment.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16298040 DOI: 10.1016/j.canlet.2005.10.006
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679